SCHEMBL14014256

SCHEMBL14014256

CCOC(=O)c1cn([C@@H]2C[C@@H]2F)c2c(C#N)c(N3CC[C@@H](C4(NC(=O)OC(C)(C)C)CC4)C3)c(F)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.42
KCNH2 Q12809 5/20 0.39
CYP3A4 P08684 1/20 0.37
ADRB2 P07550 1/20 0.36
ALDH1A1 P00352 3/20 0.35
POLB P06746 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
BTK Q06187 1/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP2C19 P33261 1/20 0.32
TOP1 P11387 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13341768 1.00 STAT3 (0.42) STAT3KCNH2CYP3A4ADRB2ALDH1A1
SCHEMBL13341766 0.92 CYP3A4 (0.45) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL14014253 0.92 CYP3A4 (0.45) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL13368166 0.83 STAT3 (0.38) STAT3KCNH2CYP3A4ALDH1A1BTK
SCHEMBL3559878 0.82 KCNH2 (0.49) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL3559880 0.82 KCNH2 (0.49) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL3556609 0.81 CYP3A4 (0.47) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL3556611 0.81 CYP3A4 (0.47) KCNH2CYP3A4ALDH1A1POLBCHRM2
SCHEMBL2670352 0.80 KCNH2 (0.38) STAT3KCNH2CYP3A4ADRB2ALDH1A1
SCHEMBL13341781 0.79 KCNH2 (0.39) STAT3KCNH2CYP3A4ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255190-A1 8-Cyanoquinolonecarboxylic Acid Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-10-16 US disclosed
US-20080255190-A1 8-Cyanoquinolonecarboxylic Acid Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255190-A1 8-Cyanoquinolonecarboxylic Acid Derivative QPCT, ASNS, C3AR1 STAT3 1608/4885KCNH2 807/4885CYP3A4 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.